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Summary. The widespread use of generalized linear models in case-control genetic stud-
ies has helped identify many disease-associated risk factors typically defined as DNA vari-
ants, or single nucleotide polymorphisms (SNPs). Up to now, most literature has focused
on selecting a unique best subset of SNPs based on some statistical perspective. When
the noise is large compared to signal, however, multiple biological paths are often found
to be supported by a given dataset. We address the ambiguity related to SNP selection
by constructing a list of models – called variable selection confidence set (VSCS) – which
contains the collection of all well-supported SNP combinations at a user-specified confi-
dence level. The VSCS extends the familiar notion of confidence intervals in the variable
selection setting and provides the practitioner with new tools aiding the variable selection
activity beyond trusting a single model. Based on the VSCS, we consider natural graph-
ical and numerical statistics measuring the inclusion importance of a SNP based on its
frequency in the most parsimonious VSCS models. This work is motivated by available
case-control genetic data on age-related macular degeneration, a widespread disease
and leading cause of vision loss.
Keywords: Variable selection confidence set, likelihood ratio test, predictor ranking,
case-control genotype data, age-related macular degeneration
1. Introduction
1.1. Motivating AMD data and variable selection uncertainty
Age-related macular degeneration (AMD) is a widespread condition causing blindness
among adults over age 50 with estimated worldwide prevalence of 8.7% (Jonas, 2014).
AMD is often referred to as a complex disease, since it is caused by the interaction of
a number of genetic, environmental and lifestyle factors, many of which have not yet
been discovered. The motivating dataset in this paper consists of case-control categorical
measurements at 20 DNA loci called single nucleotide polymporphisms (SNPs) published
through our previous work (Fritsche et al., 2013). SNPs are substitutions of a single
nucleotide (A = Adenine, T= Thymine, C=Cytosine, G=Guanine) at a specific position
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on the genome. An understanding of their role in disease is sought in order to better
diagnose, predict disease progression and personalize treatment regimens for patients.
There are a wealth of methods in the literature of model selection for selecting a single
combination of SNPs. Examples in genetics include approaches based on information-
theoretical criteria, Bayesian and frequentist sparsity-inducing penalization approaches;
e.g., see Frommlet et al. (2012); Wen (2015); Park and Hastie (2009); Wu et al. (2009);
Ayers and Cordell (2010); Li, et al. (2014). Although the usual goal of model selection
is to find a single optimal model, in the presence of pronounced noise relative to signal,
multiple models may be well supported by a given dataset. Dealing with this model
ambiguity can be challenging in diseases such as AMD due the many alternative pathways
(combinations of SNPs) potentially explaining disease and modest signal-to-noise ratio.
Focusing exclusively on a single selected model, however, implies loss of information
from different perspectives. First, alternative explanations of disease etiology are tossed
away – although these may be scientifically plausible and supported by the data. Second,
the usual standard errors for a given selected model (e.g. regression model) fail to de-
scribe the variable selection uncertainty, so they cannot be directly used for establishing
if a SNP subset is superior to other subsets. For similar reasons, ranking importance of
SNPs based on the size of estimated coefficients and their standard errors (e.g. z-scores)
may be misleading. One might argue that ranking can be achieved by marginal mea-
sures of association (e.g. chi-square or exact Fisher tests), but this would ultimately fail
to capture the role of SNP combinations, which is a key goal when studying complex
diseases.
1.2. A frequentist characterization of variable selection uncertainty
This paper proposes to resolve issues related to model ambiguity in the above AMD data
by constructing a set of plausible SNP combinations, which we call a variable selection
confidence set (VSCS). We begin by taking p SNPs where p is typically much smaller
than the sample size, n. For instance, genome-wide scans and scientific considerations
currently suggest that 20 genetic loci could play a role in AMD (Fritsche et al., 2013).
Alternatively, some conservative variable selection method is applied to reduce the num-
ber of SNPs. Such a screening should be conservative in the sense that the set of selected
SNPs should contain the relevant SNPs (but it is also allowed to contain some irrelevant
ones as well). Then, within a GLM framework, we compare all the models nested in the
full model with p predictors using a likelihood ratio test (LRT) at a given significance
level α. The final VSCS is then constructed by retaining the models not rejected by the
LRT screening procedure.
An important consequence of the above LRT screening is that the resulting VSCS is
guaranteed to contain the “true model” based on the available data with a probability
of at least 1−α as the sample size diverges. By analogy with the frequentist confidence
intervals for parameter estimation, a VSCS should be regarded as a set of plausible
models at the 100(1 − α)% given confidence level. Under standard conditions required
to ensure the asymptotic distribution of the LRT screening for GLMs, the VSCS models
include the terms in the true model with large probability in large samples. Hence, the
frequency of the selected SNPs and their combination in the VSCS models is expected to
reflect their importance in relation to the response in a principled way that goes beyond
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just trusting a single model selected by some rule.
Ferrari and Yang (2015) develop a procedure to construct variable selection confidence
sets for regression models by F-testing and study its properties. Zheng, Ferrari and Yang
(2019) extend this methodology in the context of general likelihood functions. Previously,
Hansen, Lunde and Nason (2011) propose the model confidence sets building upon step-
down methods for multiple hypothesis testing (e.g., see Lehmann and Romano (2006)).
Differently from their approach we focus specifically on LRT for GLMs in order to obtain
an asymptotic coverage probability for the globally optimal model, which is difficult to
obtain when starting from an arbitrary list of models as in Hansen, Lunde and Nason
(2011). In treatment regimes (DTR), one rule is typically selected for each stage of
patient treatment. Instead of trying to find a single optimal DTR, Wu (2016) construct
a set of DTRs such that the optimal DTR is contained in such a set with a desired
probability.
In this paper, we apply the methods in Zheng, Ferrari and Yang (2019) in the con-
text of the logistic regression model to analyze the AMD case-control genotype data.
The empirical findings in this paper and new simulation results confirm our previous
theoretical results. Further, in this paper we also explore a new way to combine the
most parsimonious models in the VSCS. Stable ranks for SNPs combinations in relation
to AMD and a central model in our VSCS is obtained by combining SNP predictors
appearing with relatively high frequency in the most parsimonious VSCS models – the
so-called lower boundary models (LBMs).
A popular approach for assessing model uncertainty is Bayesian model averaging
(BMA), which places prior distributions on the parameters along with a prior over
model space (e.g., see Bondell and Reich (2012) and references therein). While both
BMA and VSCS methodologies enable one to assess the model uncertainty and variable
importance, currently we do not have a well-developed frequentist equivalent to BMA.
The two methods carry out model uncertainty evaluation using fundamentally different
conceptual frameworks. Whilst our approach does not require any prior information
and relies entirely on frequentist arguments, BMA requires the availability of a suitable
prior distribution on the model space, which is often hard to obtain. Thus, the proposed
VSCS methodology fills the missing gap in this literature by providing a frequentist
solution to the model uncertainty problem and it is not meant to compete directly with
the Bayesian approach.
The rest of the paper is organized as follows. In Section 2, we present the main VSCS
methodology for generalized linear models, discuss the notion of lower boundary models
(LBMs) and introduce natural statistics based on the VSCS to rank predictors’ inclusion
importance. In the same section, we propose a model-combining strategy to obtain a
single representative model based on the inclusion importance ranks of predictors. In
Section 3, we study the finite sample properties of our methods using simulated genotype
data. In Section 4, we apply the new methodology and study the AMD Gene Consortium
case-control genotype data. In Section 5, we conclude and give final remarks.
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2. Methods
2.1. Setup: Generalized linear models
Generalized linear models (GLMs) play an important role in many fields of empiri-
cal research. In genetics, due to their flexibility in modelling the relationship between
predictors and a function of a response variable, GLMs have become popular tools to
investigate the association between SNPs and phenotype (e.g. disease occurrence). Let
Yi, i = 1, . . . , n, be independent phenotype measurements which are assumed to follow a
distribution from an exponential family with mean µi = E(Yi). Let xi = (xi1, . . . , xip)
T ,
i = 1, . . . , n, be p-dimensional vectors of SNP covariates. Specifically, xij = AA,Aa or
aa, where the letters “A” and “a” represent one of the nucleotide bases in {A, T,C,G}.
Other covariates representing demographic attributes of patients (e.g. gender, ethnicity,
etc.) are collected in q-dimensional vectors, zi = (zi1, . . . , ziq)
T , i = 1, . . . , n.
Let g(·) be an invertible linearizing link function mapping the expectation of the
response variable to the predictors as follows
g(µi) = ηi = β0 + β
Txi + γ
T zi, i = 1, . . . , n, (1)
where β0 ∈ R1, β = (β1, . . . , βp)T ∈ Rp, and γ = (γ1, . . . , γq)T ∈ Rq are model param-
eters. The intercept β0 and the term γ
T zi are always included in the linear predictor
(1), so the main focus is on selecting subsets of SNP predictors. Particularly, we assume
that some of the coefficients in (β1, . . . , βp) are zero and denote by m
∗ ⊆ {1, . . . , p} the
set of indexes of all non-zero terms in the true model. The full model containing all p
predictors is denoted by mf and the set of all feasible models denoted by M is defined
by taking all the nested models in mf . We assume that the sample size n is sufficiently
large so that estimates (βˆ0, βˆ, γˆ) can be obtained by standard likelihood methods.
The methods discussed in the rest of this section are rather general and can be applied
to any GLM as long as the conditions ensuring asymptotic normality of (αˆ, βˆ, γˆ) are met.
However, due the nature of the motivating AMD data application in this paper, both
numerical experiments and real data analysis in Sections 3 and 4 will focus on the logistic
regression model where Yi is a binary response representing presence/absence of AMD
and E(Yi) = P (Yi = 1) = µi represents the probability of disease for the i-th subject.
The relationship between response and covariates is modelled by the usual logit link
function log(µi)− log(1− µi) = ηi, where ηi is the linear predictor in (1).
2.2. VSCS construction by likelihood ratio testing
Given observations {(Yi,xi, zi), i = 1, . . . , n}, our main interest is to construct a set
of models, M̂α, satisfying P (m∗ ∈ M̂α) ≥ 1 − α as the sample size increases, where
0 < α < 1 is a user-defined constant and m∗ is the true model. The set M̂α is called a
variable selection confidence set and all the models in M̂α may be regarded as plausible
at the user-specified 100(1 − α)% confidence level (e.g., 95 or 99%) (Ferrari and Yang,
2015). To obtain M̂α, we compare the full model mf to a candidate model m nested in
mf by the likelihood ratio test (LRT) statistic
Dn(m) = 2 {`n(mf )− `n(m)} , (2)
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where `n(m) is the log-likelihood function evaluated at the maximum likelihood estimates
for model m. Under the null hypothesis that the model m contains the true model, Dn
follows a central chi-square distribution with p− pm degrees of freedom for large n.
The candidate model m survives the LRT evaluation if Dn(m) < χ
2(α; p−pm), where
χ2(α; ν) denotes the upper α-quantile for a chi-squared distribution with ν degrees of
freedom, and p and pm are the number of SNP predictors in mf and m, respectively.
Then we define the (1− α)%-VSCS by all the models surviving the LRT evaluation:
M̂α =
{
m ∈M : Dn(m) < χ2(α, p− pm)
}
. (3)
The full model mf is included in M̂ by default. If a model does not survive the LRT
evaluation, then such a model is considered overly risky, in the sense that it might miss
relevant predictors at the confidence level 100(1− α)%.
A direct consequence of this procedure is that the resulting VSCS M̂α includes the
true model with large probability as n→∞. Specifically, if mf 6= m∗ the VSCS satisfies
lim
n→∞P
(
m∗ ∈ M̂α
)
≥ 1− α, (4)
and in the special case where mf = m
∗, we have limn→∞ P (m∗ ∈ M̂α) = 1. This prop-
erty follows directly from the well-known convergence in distribution of the likelihood
ratio statistic Dn to the central chi-square distribution with p− pm degrees of freedom
under the null hypothesis that the smaller candidate models are the true models.
The motivating data analysis problem in this paper allows us to compute the VSCS
by an exhaustive search since the number of SNPs in the full model is relatively small
(p = 20). In other applications, however, the number of SNP predictors, p, can be
much larger than the number of observations, n. Following Ferrari and Yang (2015), in
such cases we suggest to carry out a preliminary variable screening to drop unimportant
predictors and reduce their number to be less than the sample size. Consider a variable
selection method ψ yielding a reduced full model mψ. The size of such a reduced model is
typically substantially smaller than n. For example, in the sure independence screening
procedure of Fan and Song (2010) based on marginal associations, the prescribed size
is of order n/ log(n). Treating now mψ as the full model, we can find the VSCS M̂ψ
as described previously. Alternatively, one may consider a variable selection methods
suitable for the p > n setting (e.g., Park and Hastie (2007); Xie and Huang (2009))
producing a model with a choice of a tuning parameter. For our purposes, such a tuning
parameter should be selected conservatively so that the reduced model is likely to not
miss the true predictors, whilst it may include other noise variables. If the resulting
model ψ is over-consistent, i.e. with probability going to 1 the set of selected predictors
contains all the predictors in the true model, then lim inf
n→∞ P
(
m∗ ∈ M̂ψ
)
≥ 1 − α. This
result follows directly from the asymptotic coverage of 1−α of the VSCS (Zheng, Ferrari
and Yang, 2019) . For this to hold, it is required that the screening is done based on
data from a previous study or using a portion of the data at hand. If the sample size
is too small and there is no previous data, variable screening may be done with the full
data, although there might be a bias due to reuse of the same data for both variable
screening and VSCS construction.
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Table 1. 90%-VSCSs and -LBMs for two examples. Data are generated from Model 1
in Section 3, with n = 100, p = 5, k = 3 and using uncorrelated (ρ = 0, Left table) and
correlated predictors (ρ = 0.75, Right table).
M̂α X1 X2 X3 X4 X5 p-value
m1(mf ) X X X X X 1.00
m2 X X X X 0.99
m3 X X X X 0.24
m4(m
∗) X X X 0.45
M̂α X1 X2 X3 X4 X5 p-value
m1(mf ) X X X X X 1.00
m2 X X X X 0.43
m3(m
∗) X X X 0.18
m4 X X X X 0.10
m5 X X X 0.21
m6 X X X 0.15
m7 X X 0.19
m8 X X X 0.14
m9 X X 0.22
2.3. The lower boundary models
Without additional assumptions on the true model, the VSCS can be large because many
models – roughly 2p−pm∗ – containing the true model plus unimportant terms survive
the LRT screening. We address the potential largeness of the VSCSs by focusing on a
smaller but very informative subset of the VSCS – the set of lower boundary models
(LBMs) – hereafter denoted by B̂α. The lower boundary model set, B̂α, is defined as a
subset of VSCS, containing models that do not have any nested sub-models within the
VSCS. In lay terms, the LBMs can be regarded as a subset of maximally parsimonious
models which are at the same time well-supported by the data.
As an illustration, we randomly generate two examples with 5 predictors X1, . . . , X5,
where the true model m∗ contains only X1, X2 and X3. Predictors are uncorrelated in
the first example and correlated in the second one. Table 1, shows the resulting α-level
VSCSs, which contains 4 and 9 different models. For uncorrelated data, the B̂α contains
only m4, which is the smallest model in M̂α. In the correlated example, the B̂α contains
models m7 and m9, since for these models we cannot find any further nested models in
the M̂α.
Ferrari and Yang (2015)’s study of the LBMs in the context of linear models shows
that both the cardinality of B̂α and the composition of its constituent models carry
useful information about the overall variable selection uncertainty. It is easy to check
that their results on the LBMs immediately hold for the GLM regression framework,
when the number of predictors, p, is fixed and n is large. For the purposes of the current
analysis, it is useful to summarize their results by distinguishing the following scenarios
concerning the cardinality of B̂α:
(i) Zero variable selection uncertainty. In the ideal case where we have overwhelming
information in the data, B̂α = {m∗} with large probability as n → ∞ (i.e. the
LBM set contains only the true model). This represents the ideal situation where
the sample provides us with enough information to detect all the predictors in m∗
as they appear in the unique most parsimonious description of the data.
(ii) Moderate variable selection uncertainty. A more frequent situation in real appli-
cations occurs when B̂α contains more than 1 model, but its cardinality is much
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smaller than the entire VSCS, even in the presence of pronounced noise relative to
signal. If the models in B̂α differ by only a few predictors, the ones appearing with
relatively large frequency should be regarded as important since they play a role
in a number of parsimonious and well-supported explanations of the data.
(iii) Strong variable selection uncertainty. The most challenging case is when there is
too much noise compared to signal in the sample. In this situation the size of
B̂α can be very large and the individual constituents of B̂α may contain a small
number of predictors. This means that predictor combinations are more or less
picked at random by any model-selection method. In the least favourable case, the
cardinality of B̂α can be as large as
( p
bp/2c
)
.
The above behaviour of the LBMs is confirmed in the numerical experiments presented
in Section 3, suggesting that the cardinality of B̂α and the composition of its constituent
models are helpful indicators of the total variable selection uncertainty in a sample.
As an illustration, Figure 1 (top panels) shows the number of models in M̂α (on the
log-scale) and B̂α for different sample sizes. The graphs are based on genotype data
simulated from a logistic regression model (Model 1 in Section 3 with (p, ρ) = (10, 0)
and m∗ containing 5 predictors). Regardless of the confidence level, when n is relatively
small there are multiple LBMs quite similar to the true model, each partly overlapping
with the true model. When n is large, B̂α tends to converge to a single model containing
only the true predictors. Figure 1 (bottom panels) shows the average Hamming distance
between the models in M̂α and B̂α and the true model m∗. The Hamming distance
dH(m,m
∗) between individual models in m and m∗ is defined as the number of different
terms in m compared to m∗. As n increases, the only remaining LBM is the true model.
2.4. Inclusion importance statistics
For linear models, Ferrari and Yang (2015) show that in large samples true regression
terms tend to appear in the LBMs with probability near 1, while unimportant terms
appear with small probability. Our Monte Carlo simulations in Section 3 confirm this
understanding in the context of logistic regression and motivate the following statistics to
rank the importance of predictors. The inclusion importance (II) for the j-th predictor
is defined as
ÎIα(j) =
1
|B̂α|
∑
m∈B̂α
I(xj ∈ m), (5)
where {xj ∈ m} denotes the event that the j-th predictor is included in model m, I(·) is
the indicator function and |A| denotes the cardinality of the set A. If the j-th predictor
appears in all the boundary models then its inclusion importance is ÎIα(j) = 1. If a
predictor appears only in a few LBMs, its II value is near zero.
It is useful to generalize the idea of inclusion importance by looking at the joint
and conditional frequencies for two or more predictors in B̂α. The joint importance, or
co-importance, of predictors j and k is defined by
ÎIα(j, k) =
1
|B̂α|
∑
m∈B̂α
I ({xj ∈ m} ∩ {xk ∈ m}) . (6)
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Fig. 1. Variable selection confidence set (M̂α) and lower boundary model set (B̂α) for increas-
ing sample size (n) and different confidence levels (90, 95 and 99%) for logistic regression. Top
panels: Cardinality of M̂α (on the log-scale) and B̂α. Bottom panels: Average Hamming dis-
tance between all the models in M̂α and B̂α and the true model m∗. Each point in the curves is
obtained by Monte Carlo averages based on 100 simulations from Model 1 described in Section
3 with (p, ρ) = (10, 0).
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We remark that this measure provides information on the joint utility of predictors in
relation to the response in a way that goes beyond simply measuring association between
predictors. For example, Figure 3 compares co-inclusion importance with pairwise sam-
ple mutual information (MI) for the SNPs in the AMD Genotype data detailed in Section
4. The sample MI measures the overlap between the distribution of two SNPs and is
therefore a generic measure of association. Specifically, MI = Epˆjk log{pˆjk/(pˆj pˆk)},
where pˆjk and pˆj , pˆk denote estimated joint and marginal distributions for SNPs j and
k. Note that while all but two SNP pairs are largely independent, several SNPs co-
appear with others in the LBMs with respectable frequency. This means that such pairs
contribute to a number of well-supported explanations of the response.
If ÎIα(k) > 0, the conditional importance of predictors j given k is defined by
ÎIα(j|k) = ÎIα(j, k)
ÎIα(k)
. (7)
If ÎIα(k) = 0, predictor k does not appear in the LBMs and the conditional inclusion
importance remains undefined. Given that predictor k is in the LBM, the conditional
inclusion importance statistic (7) can be used to summarize the conditional dependencies
between k and predictors in the LBM in terms of their role in explaining the response
variable.
The marginal and conditional importance statistics can be displayed in a graph as
shown in Figure 4 to represent what we call an inclusion-importance network. The
nodes in the graph represent SNPs with size proportional to the marginal inclusion
statistic, ÎIα(j). Any two nodes, say j and k, are joined by two directed edges with
thickness proportional to ÎIα(j|k) and ÎIα(k|j) with arrows pointing in the direction
k → j and j → k, respectively. Disconnected (or weakly connected) nodes represent
conditionally independent (or weakly dependent) predictors, meaning that the inclusion
of one predictor is not related to the importance of the others. Clearly, the overall degree
of connectedness and centrality of a predictor in the graph summarize the importance
of such a predictor in relation to others for explaining the response variable.
2.5. Combining lower boundary models
The set of lower boundary models is a summary statistic of the variable selection un-
certainty in the sample, where each LBM offers a partial but very plausible view of the
underlying data-generating process. It is now well understood that estimation or pre-
diction can be improved by combining models (e.g. see Claeskens, and Hjort (2008) for
a book-length exposition). Thus, in the same spirit of model combining methods, we
propose to aggregate the models in the set lower boundary models to achieve a better
predictive performance than could be obtained from any individual constituent.
Suppose that B̂α contains k ≤ p distinct predictors and let (j1, . . . , jk) denote an
arrangement of indexes in {1, . . . , k}. The LBM-aggregated model, m̂ag, is defined by
the index set
m̂ag =
{
(j1, . . . , jk˜) ∈ M̂α : ÎIα(j1) ≥ ÎIα(j2) ≥ · · · ≥ ÎIα(jk˜), k˜ ≤ k
}
, (8)
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where ÎIα(·) is the statistic defined in (5). Then, the combined model m̂ag contains the
most useful k˜ predictors as measured by their marginal II values. Where appropriate,
a value of k˜ strictly smaller than k may be used to control the complexity of the final
model and avoid predictors with nonzero but very low II value.
Although we do not offer a universally optimal rule for selecting k˜, our numerical
simulations suggest that the following step-wise strategy works well in practice. Starting
from k˜ = 1 we progressively add candidate terms based on their inclusion importance
rank, ÎIα(j), and assess the resulting model using some model-selection criterion (e.g.
AIC, BIC, etc). Then we stop if the given model-selection criterion cannot be improved
and the resulting model is in M̂α. In our Monte Carlo simulations and real data analysis
(Sections 3 and 4), we consider AIC and BIC as model selection criteria, and refer to the
resulting models as AIC-B̂α and BIC-B̂α models, respectively. Other selection criteria
(e.g. cross-validation) may be used instead, but they are not explored in the current
paper. Our numerical findings suggest that this strategy yields parsimonious yet very
informative models typically outperforming popular model-selection methods that ignore
model-selection uncertainty.
3. Monte Carlo simulations
The main aims of our simulation experiments are: 1) To investigate the finite sample
coverage probability of the VSCS; 2) To study the cardinality of the VSCS and lower
boundary model set in relation to model selection variability; and 3) To study the
performance of the LBM-aggregation strategy described in Section 2.5.
Similarly to Pan (2009) and Han and Pan (2012), we simulate genotype data by a
latent variable approach. We draw independent p-variate vectors, ui = (ui1, . . . , uip)
T ,
i = 1, . . . , n, from a multivariate normal distribution with zero mean vector, unit variance
vector and covariance matrix denoted by Σ. Then we create corresponding genotype
vectors, xi = (xi1, . . . , xip)
T , with jth element defined as
xij =
Aa, uij < c1,AA, c1 ≤ uij < c2,
aa, uij ≥ c2,
for some constants c1 and c2, with Aa, AA, aa denoting genotype labels. In the following
simulations, we set c1 = Φ
−1(1/3) and c2 = Φ−1(2/3) where Φ(·) is the standard normal
cdf. For each genotype vector, xi, we then generate binary responses with probability
pii = e
ηi/(1 + eηi), where ηi is the linear predictor defined in (1) with γ = (0, . . . , 0)
T
and β0 = 0. The following settings for β and Σ are considered:
Model 1: The first k coefficients have the same size and the rest are equal to 0: βj =
(−1)j , j = 1, . . . , k, and βj = 0, j = k + 1, . . . , p. The elements of Σ follow the Toeplitz
structure: Σij = ρ
|i−j|, 0 ≤ ρ < 1.
Model 2: Same as Model 1, but Σ is a block diagonal matrix; each block has size
(p/2)×(p/2). Elements within each block have covariance all equal to ρ, whilst between-
block covariance equal to 0.
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Model 3: The first k coefficients have decreasing size and the rest are equal to 0:
βj = (−1)j/j, j = 1, . . . , k and βj = 0, j = k + 1, ..., p. Toeplitz covariance structure as
in Model 1.
Model 4: Decreasing coefficients as in Model 2 and block-covariance structure as in
Model 3.
For simulation studies in this section, we fix k to be p/2 for the above Models 1-4.
3.1. MC Experiment 1: Cardinality/coverage of M̂α and B̂α .
Tables 2, 3 and 4 show Monte Carlo estimates for the coverage probability, P (m∗ ∈
M̂α) (the probability that the VSCS includes true model), the cardinality of VSCS
and LBM, |M̂α| and |B̂α|, and the average number of predictors in the lower boundary
models, avg|B̂α|, under different values for the sample size (n), number of predictors (p),
correlation between predictors (ρ), and significance level (α).
For all considered models, the estimated coverage probability is fairly close to the
nominal significance level, α. As expected, as α decreases, the cardinality of both VSCS
and LBMs increases. When the signal relative to noise is small – which occurs for
example when the size of the coefficients, βj , decreases, or the sample size, n, is small –
we observe coverage probability slightly smaller than the nominal probability 1− α. As
the correlation between variates increases, the variable selection uncertainty increases,
leading to larger cardinality for both VSCS and LBM. The coverage probability, however,
is rather stable irrespective of the correlation structure used to generate the covariates.
It is important to note that, differently from the VSCS, the cardinality of the LBM
is much smaller compared to the total number of feasible models, 2p. At the same
time, the LBMs contain similar information to the whole VSCS in terms of finding
the nonzero regression terms (see discussion in Section 2.3 and MC Example 2 in this
section). This confirms that the LBMs are informative summaries for measuring the
variable selection uncertainty while their contained number allows in principle to develop
efficient algorithms for their discovery in larger problems.
Finally, from Tables 3 one can see that the average size of the individual lower bound-
ary models is usually smaller than the size of the true model. Due to the effect of the
variable selection uncertainty, each LMB contains a different subset of the true model
m∗. Additional simulations show that is quite unlikely that a LBM contains unimpor-
tant variables. This confirms that the model combining strategy discussed in Section
2.5 represents a rather sound selection method in its own right.
3.2. MC Experiment 2: Model aggregation by importance ranking.
In our second Monte Carlo experiment, we focus on the LBMs and study whether the
occurrence of predictors in the LBM is informative on the true regression terms. To this
end, we consider retaining the first k˜ regression terms, ranked according to the inclusion
importance statistic (5) introduced in Section 2.5. The number of terms appearing in
the final selected model, k˜, is chosen by step-wise selection using AIC and BIC scores.
To assess the model-selection performance of our method, we compute Monte Carlo
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Table 2. Monte Carlo estimates of the coverage probability P (m∗ ∈ M̂α),under different values for the
sample size (n), number of predictors (p), correlation between predictors (ρ), and confidence level. Results
are obtained from 500 Monte Carlo runs.
n 100 200
Coverage p 8 14 8 14
Conf.(%) ρ 0 0.25 0.5 0.75 0 0.25 0.5 0.75 0 0.25 0.5 0.75 0 0.25 0.5 0.75
90 88.4 88.2 87.4 89.8 79.6 83.8 85.4 83.4 87.2 85.8 88.6 87.2 89.6 88.6 87.2 86.6
Model 1 95 94.4 94.6 93.8 95.2 86.6 90.6 91.0 90.4 93.2 92.2 95.0 92.6 93.2 94.0 93.6 93.4
99 98.6 98.8 98.6 97.8 94.6 96.8 97.6 97.2 98.4 98.6 99.2 99.0 98.4 98.4 99.2 99.0
90 88.4 88.4 86.2 87.0 79.6 80.8 80.4 81.8 87.2 91.0 88.8 88.8 89.6 87.2 87.2 86.0
Model 2 95 94.4 94.0 92.8 92.4 86.6 89.2 88.2 88.0 93.2 95.2 95.0 94.0 93.2 92.2 92.8 92.0
99 98.6 97.6 98.6 97.8 94.6 96.6 95.8 96.8 98.4 98.4 99.2 98.6 98.4 97.8 98.8 98.2
90 87.0 87.0 88.8 86.2 84.0 84.0 82.6 84.2 89.2 88.4 88.2 89.4 86.0 85.4 85.8 86.2
Model 3 95 92.0 92.0 93.6 93.0 92.2 93.4 90.8 89.2 95.6 93.6 93.6 93.0 93.4 91.8 92.6 93.8
99 97.8 98.0 98.2 99.4 98.4 99.2 97.4 97.4 99.0 98.8 98.2 99.0 98.8 98.8 98.6 98.8
90 87.0 90.0 88.0 86.4 84.0 84.4 82.8 82.8 89.2 90.2 89.4 88.4 86.0 87.8 86.4 88.0
Model 4 95 92.0 94.8 94.4 91.2 92.2 89.0 89.8 91.2 95.6 94.4 95.2 94.0 93.4 93.2 92.0 93.8
99 97.8 98.8 99.0 98.2 98.4 97.0 97.4 97.8 99.0 99.4 99.0 98.6 98.8 98.6 97.0 98.4
Table 3. Monte Carlo estimates of the cardinality of LBM sets, |B̂α|under different values for the sample
size (n), number of predictors (p), correlation between predictors (ρ), and confidence level. Results are
obtained from 500 Monte Carlo runs.
n 100 200
|B̂α| p 8 14 8 14
Conf.(%) ρ 0 0.25 0.5 0.75 0 0.25 0.5 0.75 0 0.25 0.5 0.75 0 0.25 0.5 0.75
90 1.39 1.44 1.76 2.64 4.31 4.17 5.40 7.73 1.08 1.08 1.10 1.37 1.64 1.61 2.19 4.28
Model 1 95 1.59 1.66 1.92 3.29 5.54 5.29 6.69 8.34 1.08 1.09 1.14 1.51 1.96 1.95 2.83 5.08
99 2.07 2.20 2.76 4.61 8.49 7.64 8.62 9.78 1.14 1.16 1.34 2.11 3.07 3.14 4.70 7.74
90 1.39 1.44 1.73 2.34 4.31 5.21 6.64 8.57 1.08 1.08 1.18 1.45 1.64 2.05 3.05 5.44
Model 2 95 1.59 1.66 2.10 2.91 5.54 6.34 7.80 9.74 1.08 1.10 1.16 1.59 1.96 2.64 3.83 6.95
99 2.07 2.26 2.80 4.14 8.49 9.51 9.67 10.32 1.14 1.26 1.36 2.10 3.07 3.95 5.83 9.43
90 1.85 2.04 2.21 3.00 5.55 4.69 5.54 7.53 1.71 1.69 1.65 1.77 4.52 3.99 3.64 4.57
Model 3 95 2.08 2.22 2.65 3.67 5.57 5.26 6.20 8.22 1.73 1.70 1.72 1.88 4.60 3.74 3.68 4.42
99 2.70 3.03 3.89 5.07 6.49 6.92 7.89 10.27 1.86 1.69 1.72 2.29 3.83 3.28 3.87 5.35
90 1.85 1.99 2.47 3.03 5.55 5.13 6.13 8.25 1.71 1.64 1.71 1.96 4.52 4.52 4.49 5.63
Model 4 95 2.08 2.38 2.89 3.63 5.57 5.53 6.61 8.84 1.73 1.73 1.69 2.15 4.60 4.21 4.30 5.82
99 2.70 3.44 3.93 4.96 6.49 7.23 7.97 9.92 1.86 1.72 1.88 2.62 3.83 3.88 4.64 6.83
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Table 4. Monte Carlo estimates of the average number of predictors in the lower boundary models avg(B̂α), under
different values for the sample size (n), number of predictors (p), correlation between predictors (ρ), and confidence
level. Results are obtained from 500 Monte Carlo runs.
n 100 200
avg(B̂α) p 8 14 8 14
Conf.(%) ρ 0 0.25 0.5 0.75 0 0.25 0.5 0.75 0 0.25 0.5 0.75 0 0.25 0.5 0.75
90 3.85 3.70 3.45 2.83 6.42 6.03 5.63 4.74 4.15 4.16 4.06 3.81 6.98 6.96 6.73 6.19
Model 1 95 3.61 3.42 3.06 2.52 6.11 5.73 5.19 4.18 4.06 4.05 3.90 3.54 6.82 6.74 6.50 5.75
99 3.10 2.87 2.54 1.93 5.49 4.99 4.30 3.21 3.93 3.87 3.61 3.01 6.50 6.37 6.03 5.08
90 3.85 3.59 3.33 2.70 6.42 6.13 5.60 4.64 4.15 4.10 4.05 3.68 6.98 6.87 6.69 6.03
Model 2 95 3.61 3.28 3.01 2.38 6.11 5.73 5.13 4.14 4.06 3.99 3.86 3.38 6.82 6.64 6.36 5.67
99 3.10 2.78 2.43 1.94 5.49 4.99 4.26 3.20 3.93 3.77 3.51 2.83 6.50 6.23 5.86 4.91
90 1.97 1.75 1.67 1.54 2.40 2.21 2.14 1.96 2.52 2.36 2.04 1.71 2.98 2.69 2.21 2.19
Model 3 95 1.72 1.52 1.48 1.34 2.15 1.95 1.84 1.72 2.22 2.07 1.77 1.53 2.66 2.33 1.92 1.88
99 1.40 1.22 1.25 1.15 1.69 1.57 1.49 1.37 1.85 1.59 1.39 1.26 2.03 1.76 1.56 1.61
90 1.97 1.78 1.66 1.61 2.40 2.33 2.28 2.10 2.52 2.28 2.13 1.85 2.98 2.73 2.51 2.28
Model 4 95 1.72 1.59 1.46 1.43 2.15 2.01 1.94 1.84 2.22 2.02 1.86 1.63 2.66 2.36 2.18 2.02
99 1.40 1.29 1.21 1.19 1.69 1.69 1.54 1.43 1.85 1.60 1.50 1.32 2.03 1.91 1.81 1.66
estimates of the Hamming distance dH(mˆ,m
∗) defined by the number of different terms
in a selected model mˆ compared to the true model m∗.
Table 5 shows Monte Carlo estimates of the Hamming distance for our LBM-aggregation
methods (AIC-B̂α and BIC-B̂α) and classic forward-selection based on AIC and BIC
scores (F-AIC and F-BIC). In addition, we show results for other common selection
methods based on penalization approaches: least absolute selection and shrinkage op-
erator (LASSO), smoothed clipped absolute deviation (SCAD), and mini-max convex
penalization (MCP) approaches (e.g. see Fan and Li (2001); Zhang (2009)). To compute
LASSO, SCAD and MCP we used the R package ncvreg with tuning parameters chosen
by 5-fold cross validation. The proposed LBM-aggregation methods generally outper-
form all the other selection procedures relying on a single model in most cases, regardless
of the model structure and sample size. As the sample size increases, the accuracy of
the aggregation strategy based on LBMs is found to be significantly improved compared
to single-model selection methods.
3.3. MC Experiment 3: Comparison with Bayesian model averaging.
In this experiment, we compare the VSCS method with Bayesian model averaging (BMA)
(e.g. see Claeskens, and Hjort (2008)). Table 6 shows Monte Carlo estimates of the
probability that the best model given by BMA (the model with the highest posterior
distribution) is included in the 95%-level VSCS. The BMA models are computed using
the R-package BMA (Raftery and Painter, 2005) assuming a uniform prior and setting
the maximum ratio for excluding models in Occam’s window as 20. The probability
estimates are not very large, meaning that the best BMA model varies substantially.
Table 7 shows Monte Carlo estimates of the coverage probability for BMA models under
different Occam’s window ratios (OR) and uniform prior. The results are based on 500
Monte Carlo simulations from Models 1 and 3. Our results suggest that, compared to
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Table 5. Monte Carlo estimates of the Hamming distance between the true model m∗ and models selected
by LBM-aggregation based on AIC and BIC (AIC-B̂α and BIC-B̂α), forward-selection based on AIC and BIC
(F-AIC and F-BIC), and LASSO, SCAD, MCP sparsity-inducing penalization approaches. For the LBM-
aggregation method we consider 90, 95 and 99% confidence levels. The tuning parameters for LASSO,
SCAD and MCP methods are chosen by 5-fold cross validation. Results are based on 500 simulations from
Model 1.
AIC-B̂α BIC-B̂α F-AIC F-BIC LASSO SCAD MCP
n p ρ 90% 95% 99% 90% 95% 99%
100 8 0 1.00 1.16 2.10 1.66 1.60 1.62 1.79 1.90 1.51 1.31 2.16
0.5 1.44 1.68 2.51 2.11 2.20 2.34 2.01 3.18 1.96 1.80 2.48
14 0 2.19 2.28 2.38 2.31 2.34 2.24 2.85 3.41 2.15 2.17 3.58
0.5 2.90 3.04 3.65 3.33 3.53 3.70 3.48 5.75 4.15 4.12 4.48
200 *8 0 0.48 0.50 0.84 0.36 0.31 0.38 1.67 1.13 1.41 1.04 2.31
0.5 0.57 0.66 1.58 1.04 0.90 0.93 1.63 2.12 1.38 1.08 2.59
*14 0 1.18 1.24 1.89 1.27 1.40 1.46 2.21 1.34 2.55 1.73 4.06
0.5 1.47 1.62 1.86 1.40 1.61 1.56 1.99 3.40 2.66 2.07 4.39
Table 6. Percent fraction of BMA best models included in VSCS . We set the maximum ratio for excluding
models in Occam’s window equals to 20 and use a uniform prior to obtain BMA models. Results are based
on 500 Monte Carlo simulations, with data generated from Model 1.
n 100 200
p 8 14 8 14
Conf.(%) ρ 0 0.25 0.5 0.75 0 0.25 0.5 0.75 0 0.25 0.5 0.75 0 0.25 0.5 0.75
90 0.48 0.47 0.45 0.48 0.23 0.19 0.24 0.40 0.82 0.75 0.69 0.49 0.67 0.66 0.47 0.31
95 0.59 0.59 0.57 0.63 0.32 0.29 0.34 0.54 0.87 0.83 0.76 0.60 0.77 0.75 0.58 0.44
99 0.79 0.81 0.81 0.86 0.52 0.50 0.57 0.79 0.93 0.90 0.89 0.81 0.89 0.88 0.79 0.68
VSCS, that BMA suffers from lower coverage when the correlation between predictors
increases or the number of predictors grows.
4. Analysis of the AMD Genotype data
The AMD Genotype data analysed in this section consist of measurements on patients
from either outpatient clinics at the Royal Victorian Eye and Ear Hospital or through
private ophthalmology practices in Melbourne, Australia. Control subjects were selected
from the same community. The subjects were Caucasian of Anglo-Celtic ethnic back-
ground. Patient collection and clinical examination were undertaken as described previ-
ously in Baird et al. (2004) . The cohort consisted of 418 subjects with advanced AMD
and 266 healthy control subjects with no AMD. For each patient, demographic informa-
tion was collected along with age and gender and included in our models to control for
potential confounding. The 20 SNPs considered here include 14 well-replicated variants
in the AMD risk assessment literature as well as 6 newly discovered variants (Fritsche et
al., 2013). Genomic DNA was prepared from peripheral venous blood with genotyping
of the 20 SNPs performed on the Mass Array platform (SEQUENOM, San Diego, CA)
at the Murdoch Children’s Research Institute, Melbourne as previously described in Gu
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Table 7. Percent coverage probability for BMA models under different Oc-
cam’s window ratios (OR) and uniform prior. Results are based on 500 Monte
Carlo simulations from Model 1 and Model 3.
n 100 200
p 8 14 8 14
OR ρ 0.25 0.75 0.25 0.75 0.25 0.75 0.25 0.75
Model 1 10 92.0 56.2 1.2 0.0 99.2 91.4 95.8 45.0
20 96.2 70.6 9.8 0.4 99.4 95.6 98.4 60.6
50 99.4 86.4 39.8 10.6 99.8 98.0 99.4 78.0
100 99.6 91.6 61.8 27.0 99.8 99.4 99.6 85.0
Model 3 10 13.0 5.8 0.0 0.0 20.6 4.6 0.0 0.0
20 21.0 11.2 0.0 0.0 35.0 11.2 0.4 0.0
50 40.6 21.6 0.0 0.0 54.8 22.4 0.6 0.2
100 62.8 40.6 0.6 0.2 68.0 37.8 1.8 0.2
Table 8. Variable selection summary statistics for the AMD Gene Con-
sortium data: Cardinality of VSCS and LBM sets (|M̂α| and |B̂α|), 5-
number summary statistics for the number of predictors in the LMBs,
and average Hamming distance (AHD) between pairs of LMB models,
for different confidence levels.
Conf.(%) |M̂α| |B̂α| No. predictors in LBM AHD
min Q1 median Q3 max
90 30827 43 6.0 7.0 7.0 8.5 10.0 5.2
95 57273 79 5.0 7.0 8.0 8.0 10.0 5.9
99 156459 103 4.0 5.0 6.0 7.0 10.0 6.1
et al. (2013).
4.1. VSCS, LBMs and ranks of SNPs.
Table 8 shows summary statistics for the VSCS and LBM set at the 90, 95 and 99% con-
fidence levels. As expected, the cardinality of both M̂α and B̂α decrease as α increases
and the cardinality for the variable selection confidence set, |M̂α|, is much larger com-
pared to that of the LBM set, |B̂α|. The number of lower boundary models is relatively
large (43, 79 and 103) with a median number of SNPs for individual LBMs ranging
from 6 to 8, thus evidencing considerable model uncertainty. We also report the average
hamming distance (AHD) for all model pairs in the LBM computed as
AHD =
(|B̂α|
2
)−1 ∑
m,m′∈B̂α:m 6=m′
dH(m,m
′),
where dH(m,m
′) denotes the number of SNPs at which m and m′ are different. This
quantity remains stable with α and is not negligible compared to the total number of SNP
(20 SNPs), which indicates heterogeneous SNP combinations in the LBMs. Overall, the
findings in Table 8 show that the variable-selection uncertainty is quite strong, despite
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Fig. 2. SNPs ranking for the AMD gene consortium data based on the marginal inclusion
importance statistic, ÎI, computed from 95% LBM. (a)The ÎI for all the SNPs (b) ÎI for 5 SNPs
and 5 random generated predictors.
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the relatively large sample size (n = 684) and suggest that the data may not be be well
represented unequivocally by a single logistic regression model selected by a method that
ignores the selection-uncertainty.
Figure 2 summarizes SNP ranking according to the marginal inclusion importance
statistic defined in (5). Note that 15 SNPs exhibit non-zero importance, about half of
which receive II values greater than 1/2. Figure 4 illustrates the conditional inclusion
importance graph for SNPs in the AMD data. A few SNPs with large marginal inclusion
importance are central in the graph (e.g. see rs4420638, rs3130783). This suggests
that such SNPs may play an important role in relation to AMD etiology in the presence
of a number of other SNPs connected in the graph. On the other hand, certain SNPs,
such as rs10490924, seem to be important in their own right regardless of the presence
of other SNPs. Such SNPs lay on the periphery of the inclusion importance graph,
meaning that they do not explain much of the disease occurrence conditionally to the
presence of other SNPs.
The contention that removal of predictors that are essentially predictive of each other
is common in practice under the assumption of linkage disequilibrium (LD) (i.e. nonzero
association between SNPs). For example, SNPs rs10490924 and rs11200638 in the
ARMS2/HTRA1 region are highly correlated (Figure 3, right). However, our methodol-
ogy suggests that the inclusion of either SNP does not automatically lead to the exclusion
of the other. Actually, although rs11200638 has smaller marginal II value compared to
that of rs10490924, Figure 3 (left) shows that the two SNPs are important in explaining
AMD occurrence when they are observed simultaneously, suggesting that there may be
more unexplained factors at play.
In the conditional inclusion importance graph, of note is the centrality of the ApoE
gene. Changes in this gene are known to be related to AMD. It is presently unknown
what the role of ApoE is in relation to the functional mechanism of effect with respect to
allelic variation, although it is widely known that allelic variation can lead to significantly
increased risk of risk development of the aforementioned diseases. Figure 3 suggest that
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Fig. 3. Co-inclusion importance at the 95% confidence level and sample mutual information
for pairs of SNPs in the AMD genotype data. Left: Standardized co-inclusion importance
ÎIα(j, k)/ÎIα(j or k), where ÎIα(j or k) = ÎIα(j) + ÎIα(k)− ÎIα(j, k) is the relative frequency
of either SNP j or k in the LBMs. Right: Pair-wise sample mutual information for SNPs xj and
xk.
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multiple genetic variants together with ApoE are intertwined with disease etiology.
4.2. A comparison with previously reported and newly discovered loci.
Columns 1–3 in Table 9 list newly discovered and established SNPs. Columns 4–5 com-
pare the SNPs newly discovered by the AMD Gene Consortium with the results of our
ranking method using the 95% confidence level. It is reassuring that our approach iden-
tifies most of the well-replicated SNP predictors, confirming the validity of our approach.
Specifically, for the 12 well-replicated SNP variants, all except SNP rs920915 show non-
zero inclusion importance, largely confirming the current consortium list. In addition,
our method finds two SNPs not currently part of the current consortium list (rs1061170
and rs11200638 with respectable II values ranking 5th and 11th). These are well known
SNPs reputed important by other studies corresponding to the CFH and HTRA1 genes.
Of the 6 newly found SNPs, only two receive non-zero inclusion importance, meaning
that there is little evidence in these data to suggest that the remaining 4 SNPs con-
tribute much information to explain AMD occurrence beyond that already provided by
the other SNPs with positive inclusion importance values.
Model combining and variable selection. It may be reasoned that the SNP predictors
with highest II values are also the most pertinent to disease etiology. However, there is
no total presence of any single SNP in every LBM model. The implication of a lack of
unanimity points toward multiple possible disease pathways and highlights the variable
selection uncertainty faced in generating AMD risk models. Nonetheless, a collection of
stable SNPs can be obtained using the aggregation strategy proposed in Section 2.5.
Table 9 (Columns 6–9) shows the result of our LBM-aggregation approach via AIC
and BIC dimension reduction (AIC-B̂α and BIC-B̂α). For illustration purposes, we also
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Fig. 4. Conditional inclusion importance graph at the 95% confidence level for SNPs in the
AMD genotype data. The size of the nodes and thickness of edges is proportional to marginal
and conditional inclusion importance defined in (5) and (7), respectively. Edges with conditional
inclusion importance less than 0.7 are omitted for clarity.
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report the selection obtained by other popular model-selection methods. First, note that
none of the SNPs with zero II values are selected by the considered variable selection
methods, confirming the stability of our ranking scheme. Second, we illustrate that some
of the models selected by standard methods may miss some of the important SNPs at
the 95% confidence level. Specifically, the LRT p-value for the BIC model selected by
forward search (F-BIC) is smaller than α = 0.05. This means that the F-BIC model
is outside the VSCS and should be regarded as overly parsimonious since it is likely to
miss one or more important SNPs related to AMD.
5. Conclusion and final remarks
Variable selection uncertainty is a very common but often overlooked issue in applica-
tions of generalized linear models. In case-control genetic studies, the common practice
of explaining a phenotype in terms of a single SNP combination may be inadequate
when small signal-to-noise ratio prevents one to learn whether the selected combination
of predictors is the true explanation behind disease. As a consequence, often multi-
ple SNP combinations are found to be compatible with a sample depending on the
level of noise, statistical model adopted, and variable-selection method. To address this
model-selection ambiguity, we extended previous work by Ferrari and Yang (2015) and
introduced the notion of variable selection confidence set (VSCS) based on LRT screen-
ing for GLMs. We applied the new approach to rank genetic factors underpinning AMD
– an important eye disease with high prevalence in the global population – obtaining a
stable selection of SNPs based on available AMD case-control data.
The VSCS contains models statistically equivalent to the true model at a pre-specified
confidence level (e.g. 99% or 95%), thus representing a natural extension of the familiar
confidence intervals for parameter estimation in the variable selection setting. We eval-
uated the validity of VSCSs constructed by LRT screening using simulated SNP data
where the signal is not so clear, which we believe is very common in complex diseases.
With adequate sample size, our results indicate that the coverage probability of the true
model is near the nominal confidence level. Our numerical findings confirm earlier re-
sults by Ferrari and Yang (2015) in the context of linear regression and suggest that the
cardinality and composition of the lower boundary models can be used to assess both
variable selection uncertainty and learn the true model structure.
The VSCS methodology provides the practitioner with new tools in support of the
variable selection activity in a way that goes beyond trusting a single selected model.
Here we advocate the importance of a special subset of the VSCS, the lower bound-
ary model set, B̂α (i.e. the set of maximally parsimonious models surviving the LRT
screening). Our numerical examples confirm that, collectively, the models in B̂α contain
a wealth of information on the true underlying model structure which can be used for
variable ranking. Specifically, the frequency of predictors appearing in the LBMs (i.e.
the II statistic defined in (5)) is a natural measure of their relevance in explaining the
response. For example, a predictor with II value near 1 plays a role in most of the
parsimonious and plausible explanations of the data. Ranking predictors based on the
II statistics is found to be a reliable indicator of whether a given regression term is
contained in the true model when the signal is small compared to noise. Similarly, the
20 C. Zheng, D. Ferrari, M. Zhang, P. Baird
Table 9. SNPs selection and ranking for the AMD gene
consortium data grouped in previously reported (Rows
1–14) and newly discovered (rows 15–20) SNPs in the
AMD literature. Columns 1–3: SNP, chromosome and
gene identifiers. Column 4: SNPs previously identi-
fied as important. Column 5: Marginal inclusion impor-
tance statistic defined in (5). Columns 6–7: Models
selected by the LBM-aggregation strategy described
in Section 2.5 with number of variables, k˜, selected
via AIC and BIC ( AIC-B̂α and BIC-B̂α). Columns: 8–
9: Models selected by AIC and BIC step-wise forward
search. The last row denotes the p-value from the LRT
comparing the full model with 20 predictors with the
selected models.
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joint (conditional) frequency of two or more predictors in the LMBs is informative on
their joint (conditional) importance for explaining the response. In Sections 2.4 and 4 we
explained how this information can be effectively conveyed visually, for example using
common directed graphs.
Another contribution of this paper is a new approach for selecting a single central
model based on the II ranks of predictors (Section 2.5). Our Monte Carlo simulations
suggest that model aggregation by II-ranking is potentially a rather effective model-
selection strategy in its own right typically outperforming other established model-
selection approaches that do not benefit from selection-stability control. Due to these
promising results, we believe that developing a theoretical understanding of the proper-
ties of this new aggregation approach in the future, including optimal selection of the
reduced model size (k˜), would be very valuable.
In the AMD Genotype data application, various models selected by certain classic
variable selection methods are suboptimal in finding SNPs that are known to explain
AMD etiology. Particularly, aggressive selection methods promoting very sparse models
such as BIC are found to fall outside the VSCS. The usefulness of the proposed statistical
framework for novel variant investigation is shown in the identification of SNPs in a set
of well-replicated variants. The lower boundary set of models was found to identify
the vast majority of well-replicated variants presented by the AMD Gene Consortium.
In novel variant investigation, the VSCS aids by screening out newly found SNPs by
genome-wide scans that do not contribute much information when considered together
with well-established SNPs.
In the AMD Genotype data motivating this paper, the total number of SNPs in the
full model is relatively small (p = 20). Thus, our methodology is adequately handled by
generation of the entire confidence set and exhaustive LRT screening. Clearly, the ex-
ponential increase in models per additional SNP forces alternate methods more efficient
at deriving a representative confidence and lower boundary sets. To address this issue,
in our future work, we plan to extend the current procedure and develop a screening
approach based on test statistic designed to handle a large number of predictors. These
may be complemented by computationally efficient methods that can handle computa-
tion on larger model spaces. For example, we believe that certain Markov Chain Monte
Carlo methods such as the reworked Gibbs sampler described in Qian and Field (2012)
may be used to overcome these computational issues.
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